(Q36577293)

15 August 2017

1 reference

title

Therapy insight: neurological complications of prediabetes (English)

1 reference

15 August 2017

J Robinson Singleton

1

1 reference

15 August 2017

A Gordon Smith

series ordinal

2

1 reference

15 August 2017

1 May 2006

1 reference

Nature Clinical Practice Neurology

15 August 2017

1 reference

15 August 2017

2

1 reference

15 August 2017

276-282

1 reference

15 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpneuro0172

15 August 2017

0 references

cites work

The spectrum of neuropathy in diabetes and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

Essential hypertension and cognitive function. The role of hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

Painful sensory neuropathy: prospective evaluation using skin biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

Cardiovascular morbidity and mortality associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Microvascular complications of impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Diabetes and diabetes risk factors in second- and third-generation Japanese Americans in Seattle, Washington.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Painful sensory polyneuropathy associated with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Classification, differential diagnosis, and staging of diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

The relationship between blood glucose concentration and beat-to-beat variation in asymptomatic subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Impaired glucose tolerance in nondiabetic lumbosacral radiculoplexus neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Polyneuropathy with Impaired Glucose Tolerance: Implications for Diagnosis and Therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Carotid artery stenosis is related to blood glucose level in an elderly Caucasian population: the Hoorn Study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Glucose tolerance and cognitive impairment in an elderly population

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III).

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0172

7 January 2021

Identifiers

DOI

10.1038/NCPNEURO0172

1 reference

Dimensions Publication ID

15 August 2017

1007614651

0 references

Fatcat ID

release_5fclu2g3vncqxnkfnrwe2n7bce

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5fclu2g3vncqxnkfnrwe2n7bce

24 November 2022

mapped directly with Wikidata item

1 reference